Publications
- Antiplatelet efficacy of P2Y12 inhibitors (prasugrel, ticagrelor, clopidogrel) in patients treated with mild therapeutic hypothermia after cardiac arrest due to acute myocardial infarction2016 | Third Faculty of Medicine, Faculty of Mathematics and Physics
- Antiplatelet effect of prasugrel and clopidogrel in hypothermic patients after cardiac arrest for acute myocardial infarction2014 | Third Faculty of Medicine, Faculty of Mathematics and Physics
- Management of Antiplatelet Therapy in Patients at Risk for Coronary Stent Thrombosis Undergoing Non-Cardiac Surgery2011 | Third Faculty of Medicine
- Optimal pretreatment timing for high load dosing (600 mg) of clopidogrel before planned percutaneous coronary intervention for maximal antiplatelet effectiveness2010 | First Faculty of Medicine, Third Faculty of Medicine
- A comparison of the VASP index between patients with hemodynamically complicated and uncomplicated acute myocardial infarction2010 | Third Faculty of Medicine
- Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel2009 | Third Faculty of Medicine
- The time has come for new, more precise guidelines in the treatment of high-risk acute coronary syndromes with heparin2008 | Third Faculty of Medicine
- Prognosis of patients with mechanical ventilation in the acute phase of myocardial infarction in the era of primary coronary intervetniton2007 | Third Faculty of Medicine
- P2Y(12) inhibitor loading time before elective PCI and the prevention of myocardial necrosis2024 | Third Faculty of Medicine
- Trends in outcomes of women with myocardial infarction undergoing primary angioplasty - Analysis of randomized trials2023 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
Loading network view...